Skip to main content
. 2022 Sep 19;68(8):1059–1063. doi: 10.1590/1806-9282.20220199

Table 2. Implantable cardioverter-defibrillator indication agreement according to the degree of evidence.

ESC 2014
AHA 2020 III IIb IIa
III 12 0 1
IIb w6 1 5
IIa 16 13 27

General agreement: 64.2%, kappa 0.270 (95%CI 0.118–0.422; p=0.003)

ESC: European Society of Cardiology; AHA: American Heart Association. IIa, IIb, III: degrees of scientific evidence for implantable cardioverter-defibrillator; implantation according to each guideline.